Table 2: Antimicrobial resistance pattern of 25 ESBL-PE uropathogenic isolates from UTI inpatients at ATCH in Khartoum state, Sudan.
|
Antibiotics |
R in ESBLs-PE (%) |
|
Cefotaxime |
25 (100%) |
|
Aztreonam |
14 (56.0%) |
|
Ceftazidime |
25 (100%) |
|
Cefpodoxime |
18 (72.0%) |
|
Amikacin |
18 (72.0%) |
|
Ciprofloxacin |
16 (64.0%) |
|
Co-trimoxazole |
25 (100%) |
|
Gentamicin |
9 (36.0%) |
|
Nitrofurantoin |
23 (92.0%) |
*R: Resistance; ESBLs-PE; ESBL producing Enterobacteriaceae.